[Value and limits of antiplatelet agents in cerebral ischemic pathology].
The authors have reviewed the role of platelets in thromboembolic strokes, the effects of usual antiplatelet drugs on haemostasis and the new approaches to the prevention of thrombosis. Critical analysis of controlled clinical trials indicates only aspirin use showed evidence of effectiveness in prevention of transient ischemic attacks or minor strokes related to atherosclerosis.
Milandre
L
L
Clinique Neurologique, CHU Timone, Marseille.
Bonnefoi
B
B
Aillaud
M F
MF
D001241:Aspirin / Q000627:therapeutic use; D002545:Brain Ischemia / Q000188:drug therapy*; D006801:Humans; D002542:Intracranial Embolism and Thrombosis / Q000188:drug therapy*; D010975:Platelet Aggregation Inhibitors / Q000627:therapeutic use*
D010975:Platelet Aggregation Inhibitors; D001241:Aspirin
Intérêts et limites des agents antiplaquettaires en pathologie ischémique cérébrale.